HK Stock MarketDetailed Quotes

03869 HOSPITAL CORP

Watchlist
  • 5.600
  • 0.0000.00%
Not Open Nov 25 16:08 CST
773.89MMarket Cap-52336P/E (TTM)

HOSPITAL CORP Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
0.23%719.5M
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
-2.84%399.21M
-13.36%180.68M
7.11%410.88M
Operating income
0.23%719.5M
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
-2.84%399.21M
-13.36%180.68M
7.11%410.88M
Cost of sales
5.15%-566.88M
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
13.56%-204.89M
19.43%-99.98M
-2.39%-237.02M
Operating expenses
5.15%-566.88M
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
13.56%-204.89M
19.43%-99.98M
-2.39%-237.02M
Gross profit
27.02%152.62M
58.64%239.36M
66.52%120.15M
-29.57%150.88M
-27.30%72.16M
10.24%214.23M
22.98%99.25M
11.77%194.33M
-4.43%80.7M
14.29%173.87M
Selling expenses
74.64%-160K
-355.81%-1.57M
-123.76%-631K
82.85%-344K
66.39%-282K
-50,050.00%-2.01M
---839K
55.56%-4K
----
95.59%-9K
Administrative expenses
-0.89%-49.64M
-35.81%-129.23M
-39.51%-49.2M
0.74%-95.16M
-67.48%-35.27M
-84.73%-95.87M
28.64%-21.06M
19.58%-51.9M
12.50%-29.51M
-1.92%-64.54M
Impairment and provision
----
100.19%884K
----
20.11%-462.15M
15.76%-460.95M
15.34%-578.46M
18.57%-547.2M
-43,119.23%-683.3M
---671.97M
---1.58M
-Impairment of intangible assets
----
----
----
16.61%-460.28M
15.19%-460.28M
17.40%-551.98M
18.78%-542.72M
---668.22M
---668.22M
----
-Other impairment is provision
----
147.35%884K
----
92.95%-1.87M
85.23%-662K
-75.61%-26.48M
-19.42%-4.48M
-853.64%-15.08M
---3.75M
---1.58M
Special items of operating profit
491.54%10.98M
180.06%105.05M
105.94%1.86M
-585.35%-131.21M
-123.26%-31.23M
-80.83%27.04M
-258.31%-13.99M
103.53%141.03M
-79.50%8.84M
226.53%69.29M
Operating profit
57.67%113.81M
139.87%214.5M
115.84%72.18M
-23.65%-537.99M
5.84%-455.57M
-8.81%-435.07M
20.93%-483.84M
-325.86%-399.84M
-752.29%-611.94M
423.07%177.03M
Financing income
-140.65%-52.36M
-32.71%9.82M
1,491.23%128.79M
116.83%14.6M
118.99%8.09M
-63.45%6.73M
-82.50%3.7M
-56.25%18.42M
-16.34%21.12M
1,508.17%42.1M
Financing cost
----
12.13%-8.12M
----
55.50%-9.24M
68.21%-4.09M
61.84%-20.76M
-15.95%-12.86M
-130.83%-54.4M
-81.22%-11.09M
-26.85%-23.57M
Earning before tax
-69.43%61.45M
140.59%216.2M
144.51%200.97M
-18.60%-532.63M
8.41%-451.56M
-3.05%-449.1M
18.09%-493M
-322.85%-435.82M
-632.95%-601.91M
993.59%195.57M
Tax
-55.92%-35.95M
-1,287.30%-47.86M
-261.57%-23.06M
-95.35%4.03M
-82.72%14.27M
487.68%86.71M
136.47%82.58M
156.49%14.75M
293.86%34.92M
36.76%-26.12M
After-tax profit from continuing operations
-85.67%25.5M
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
-348.50%-421.07M
-697.31%-566.99M
823.48%169.45M
Earning after tax
-85.67%25.5M
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
-348.50%-421.07M
-697.31%-566.99M
823.48%169.45M
Minority profit
-14.47%44.22M
177.57%36.96M
--51.7M
41.67%-47.65M
----
-388.35%-81.69M
-119.44%-69.32M
-190.19%-16.73M
-344.95%-31.59M
-31.49%18.55M
Profit attributable to shareholders
-114.83%-18.72M
127.32%131.38M
128.86%126.22M
-71.33%-480.95M
-28.20%-437.29M
30.58%-280.71M
36.29%-341.1M
-367.95%-404.34M
-752.70%-535.4M
398.87%150.9M
Basic earnings per share
-115.38%-0.14
127.47%0.956
129.45%0.91
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
-367.95%-2.926
-751.52%-3.87
396.74%1.092
Diluted earnings per share
-600.00%-0.14
106.12%0.213
99.35%-0.02
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
-1,383.33%-2.926
-77,500.00%-3.87
161.96%0.228
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 0.23%719.5M24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M-2.84%399.21M-13.36%180.68M7.11%410.88M
Operating income 0.23%719.5M24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M-2.84%399.21M-13.36%180.68M7.11%410.88M
Cost of sales 5.15%-566.88M-19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M13.56%-204.89M19.43%-99.98M-2.39%-237.02M
Operating expenses 5.15%-566.88M-19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M13.56%-204.89M19.43%-99.98M-2.39%-237.02M
Gross profit 27.02%152.62M58.64%239.36M66.52%120.15M-29.57%150.88M-27.30%72.16M10.24%214.23M22.98%99.25M11.77%194.33M-4.43%80.7M14.29%173.87M
Selling expenses 74.64%-160K-355.81%-1.57M-123.76%-631K82.85%-344K66.39%-282K-50,050.00%-2.01M---839K55.56%-4K----95.59%-9K
Administrative expenses -0.89%-49.64M-35.81%-129.23M-39.51%-49.2M0.74%-95.16M-67.48%-35.27M-84.73%-95.87M28.64%-21.06M19.58%-51.9M12.50%-29.51M-1.92%-64.54M
Impairment and provision ----100.19%884K----20.11%-462.15M15.76%-460.95M15.34%-578.46M18.57%-547.2M-43,119.23%-683.3M---671.97M---1.58M
-Impairment of intangible assets ------------16.61%-460.28M15.19%-460.28M17.40%-551.98M18.78%-542.72M---668.22M---668.22M----
-Other impairment is provision ----147.35%884K----92.95%-1.87M85.23%-662K-75.61%-26.48M-19.42%-4.48M-853.64%-15.08M---3.75M---1.58M
Special items of operating profit 491.54%10.98M180.06%105.05M105.94%1.86M-585.35%-131.21M-123.26%-31.23M-80.83%27.04M-258.31%-13.99M103.53%141.03M-79.50%8.84M226.53%69.29M
Operating profit 57.67%113.81M139.87%214.5M115.84%72.18M-23.65%-537.99M5.84%-455.57M-8.81%-435.07M20.93%-483.84M-325.86%-399.84M-752.29%-611.94M423.07%177.03M
Financing income -140.65%-52.36M-32.71%9.82M1,491.23%128.79M116.83%14.6M118.99%8.09M-63.45%6.73M-82.50%3.7M-56.25%18.42M-16.34%21.12M1,508.17%42.1M
Financing cost ----12.13%-8.12M----55.50%-9.24M68.21%-4.09M61.84%-20.76M-15.95%-12.86M-130.83%-54.4M-81.22%-11.09M-26.85%-23.57M
Earning before tax -69.43%61.45M140.59%216.2M144.51%200.97M-18.60%-532.63M8.41%-451.56M-3.05%-449.1M18.09%-493M-322.85%-435.82M-632.95%-601.91M993.59%195.57M
Tax -55.92%-35.95M-1,287.30%-47.86M-261.57%-23.06M-95.35%4.03M-82.72%14.27M487.68%86.71M136.47%82.58M156.49%14.75M293.86%34.92M36.76%-26.12M
After-tax profit from continuing operations -85.67%25.5M131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M-348.50%-421.07M-697.31%-566.99M823.48%169.45M
Earning after tax -85.67%25.5M131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M-348.50%-421.07M-697.31%-566.99M823.48%169.45M
Minority profit -14.47%44.22M177.57%36.96M--51.7M41.67%-47.65M-----388.35%-81.69M-119.44%-69.32M-190.19%-16.73M-344.95%-31.59M-31.49%18.55M
Profit attributable to shareholders -114.83%-18.72M127.32%131.38M128.86%126.22M-71.33%-480.95M-28.20%-437.29M30.58%-280.71M36.29%-341.1M-367.95%-404.34M-752.70%-535.4M398.87%150.9M
Basic earnings per share -115.38%-0.14127.47%0.956129.45%0.91-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47-367.95%-2.926-751.52%-3.87396.74%1.092
Diluted earnings per share -600.00%-0.14106.12%0.21399.35%-0.02-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47-1,383.33%-2.926-77,500.00%-3.87161.96%0.228
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data